Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MB |
| Upstream (Parents) |
|---|
| (<<) MYH7///MYH6 → MB |
| (<<) TNNI1 → MB |
| Downstream (Children) |
|---|
| MB → MYH7 (>>) |
| MB → EML2 (>>) |
| MB → TPM3 (>>) |
| MB → TPM1 (>>) |
| MB → ATP2A1 (>>) |
| MB → ZNF221 (>>) |
| MB → MYL3 (>>) |
| MB → HOXC8 (>>) |
| MB → FBXO40 (>>) |
| MB → TNNC1 (>>) |
| MB → MYOZ2 (>>) |
| MB → TNNT1 (>>) |
| MB → LDB3 (>>) |
| MB → SYNPO2L (>>) |
| MB → MYBPC2 (>>) |
